Overcoming Barriers to the Market Access of Biosimilars in the European Union: The Case of Biosimilar Monoclonal Antibodies

Overcoming Barriers to the Market Access of Biosimilars in the European Union: The Case of Biosimilar Monoclonal Antibodies

Item
http://www.wikidata.org/entity/Q26738325
Assessing gastroenterologist and patient acceptance of biosimilars in ulcerative colitis and Crohn's disease across GermanyThe trends and constructive ambiguity in international agreements on intellectual property and pharmaceutical affairs: Implications for domestic legislations in low- and middle-income countries.Assessing physician and patient acceptance of infliximab biosimilars in rheumatoid arthritis, ankylosing spondyloarthritis and psoriatic arthritis across Germany.Molecular and functional analysis of monoclonal antibodies in support of biologics development.Improving Access to Cancer Treatments: The Role of Biosimilars.Impact of Infliximab and Etanercept Biosimilars on Biological Disease-Modifying Antirheumatic Drugs Utilisation and NHS Budget in the UK.Physiological effects of a novel artificially synthesized antimalarial cyclic peptide: Mahafacyclin B.Patient Access, Unmet Medical Need, Expected Benefits, and Concerns Related to the Utilisation of Biosimilars in Eastern European Countries: A Survey of Experts.Comparative Price Analysis of Biological Products for Treatment of Rheumatoid Arthritis
P2860

Overcoming Barriers to the Market Access of Biosimilars in the European Union: The Case of Biosimilar Monoclonal Antibodies

Item
http://www.wikidata.org/entity/Q26738325
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Overcoming Barriers to the Mar ...... osimilar Monoclonal Antibodies
@ast
Overcoming Barriers to the Mar ...... osimilar Monoclonal Antibodies
@en
Overcoming Barriers to the Mar ...... osimilar Monoclonal Antibodies
@nl
type
label
Overcoming Barriers to the Mar ...... osimilar Monoclonal Antibodies
@ast
Overcoming Barriers to the Mar ...... osimilar Monoclonal Antibodies
@en
Overcoming Barriers to the Mar ...... osimilar Monoclonal Antibodies
@nl
prefLabel
Overcoming Barriers to the Mar ...... osimilar Monoclonal Antibodies
@ast
Overcoming Barriers to the Mar ...... osimilar Monoclonal Antibodies
@en
Overcoming Barriers to the Mar ...... osimilar Monoclonal Antibodies
@nl
P1433
P1476
P2093
P2860
P304
P31
P3181
P356
P407
P478
P50
P577
P698
P921
P932
P3181
P356
P1433
P1476
Overcoming Barriers to the Mar ...... osimilar Monoclonal Antibodies
@en
P2093
P2860
P304
P31
P3181
P356
P407
P478
P50
P577
P698
P921
P932